Novartis AG
Net Cash Flow Breakdown
Total Cash from Operations: $11.48B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $1.86B | 16.2% |
| Other Investing | $1.58B | 13.8% |
| Stock Repurchases | $992.0M | 8.6% |
| Other Financing | $4.32B | 37.7% |
| Other | $387.0M | 3.4% |
| Net Cash Flow | $2.33B | 20.3% |